lawsuits Tagged Articles

Canadian class action filed against Johnson & Johnson over vaginal mesh injuries

Posted: April 19, 2012 Pharmaceutical

Lawyers in Ontario, Canada have launched a class action lawsuit against health care products manufacturer Johnson & Johnson and other companies over injuries allegedly caused by transvaginal mesh products that were used to treat women with pelvic organ prolapse (POP)

Bayer shells out millions to settle more Yaz lawsuits

Posted: April 17, 2012 Pharmaceutical

Bayer, maker of the blockbuster birth control pills Yaz and Yasmin, will pay at least $120 million to settle about 500 lawsuits claiming that the pills caused dangerous and sometimes deadly blood clots. The settlement is the first wave of

Women file birth defect lawsuits against SSRI makers

Posted: April 13, 2012 Pharmaceutical

Attorneys are taking up the fight against pharmaceutical companies for women who say the antidepressants they were taking while pregnant caused their babies to be born with serious birth defects. The women claim that the drug companies knew the medications

FDA puts stronger blood clot warnings on Yaz, Yasmin birth control pills

Posted: April 11, 2012 Pharmaceutical

Yaz and other newer birth control pills that contain the hormone drospirenone will get stronger warnings on their labels warning users that the drugs may be more likely than older oral contraceptives to cause blood clots, the Food and Drug

Unnecessary surgeries were performed for profit and promotion, whistleblower lawsuit alleges

Posted: April 11, 2012 Consumer Fraud

A whistleblower lawsuit filed against The University of Pittsburgh Medical Center’s (UPMC) Hamot campus under the False Claims Act accuses the hospital and five cardiologists of defrauding Medicare and a number of patients by participating in a kickback scheme from

FDA plans 2-day metal hip device review

Posted: April 7, 2012 Pharmaceutical

Responding to growing concerns over complications associated with metal-on-metal hip implant devices, the U.S. Food and Drug Administration (FDA) said it has planned a two-day review of the devices in June that could result in tougher regulations.

Whistleblower receives $21 million for exposing health care fraud

Posted: April 5, 2012 Consumer Fraud

A former senior financial analyst for a Florida-based health plan provider will receive nearly $21 million for his role in exposing his employer’s fraudulent business practices, which involved double billing Medicare and Medicaid.

Consumer Reports takes aim at FDA’s device approval process

Posted: April 5, 2012 Pharmaceutical

Janet Holt’s doctor told her that surgery to remove her uterus and insert a bladder lift would have her out of work for just two weeks. After that, she should be able to return to work on the family’s cattle

Lexapro soon to be available in generic form

Posted: March 30, 2012 Pharmaceutical

The drug patent for the antidepressant Lexapro expired in March 2012, paving the way for competitors to sell generic versions. Lexapro is in a class of drugs known as selective serotonin reuptake inhibitors (SSRIs), one of the most prescribed medications

Toyota can’t force arbitration in sudden unintended acceleration cases, judge rules

Posted: March 29, 2012 Consumer Fraud

Toyota can’t force arbitration of economic-loss claims filed by plaintiffs who allege the carmaker’s sudden-unintended-acceleration defects led to diminished market value for their vehicles, U.S. District judge James Selna has ruled.